Organogenesis
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $225,607 | $150,864 | $100,779 | $86,693 |
Gross Profit | 114,613 | 73,149 | 62,970 | |
EBITDA | 69,710 | 27,259 | -6,255 | -15,893 |
EBIT | 62,849 | 22,388 | -10,830 | -20,179 |
Net Income | 63,576 | 21,567 | -9,392 | -18,843 |
Net Change In Cash | 225,607 | 150,864 | 100,779 | 86,693 |
Free Cash Flow | 34,768 | 844 | -36,511 | -23,561 |
Cash | 93,679 | 64,372 | 73,076 | 109,965 |
Basic Shares | 132,206 | 130,848 | 126,853 | 126,295 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $564,169 | $482,043 | $433,140 | $450,893 |
Gross Profit | 366,302 | 326,659 | 345,874 | |
EBITDA | 67,847 | 15,763 | 36,031 | 40,322 |
EBIT | 49,251 | -1,263 | 12,582 | 22,291 |
Net Income | 56,908 | 861 | 4,945 | 15,532 |
Net Change In Cash | 564,169 | 482,043 | 433,140 | 450,893 |
Cost of Revenue | -11,238 | |||
Free Cash Flow | -24,460 | 4,176 | 6,553 | -9,039 |
Cash | 93,679 | 135,571 | 104,338 | 102,478 |
Basic Shares | 130,248 | 131,673 | 132,746 | 132,383 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | $0.40 |
2025-09-30 | $0.12 |
2025-06-30 | -$0.10 |
